Patent details

Basic Information

Publication number:

EP1156856

PCT Application Number:

PCT/EP/2000/001626

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP009125154

PCT Publication Number:

WO/2000/051577

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF FLUORINATED TRIAZOLES FOR THE TREATMENT OF NEUROPATHIC PAIN

French Title of Invention:

UTILISATION DE TRIAZOLES FLUORES DANS LE TRAITEMENT DES DOULEURS NEUROPATHIQUES

German Title of Invention:

VERWENDUNG VON FLUORIERTEN TRIAZOLEN ZUR BEHANDLUNG VON NEUROPATHISCHEM SCHMERZ

SPC Number:

Dates

Filing date:

28/02/2000

Grant date:

31/08/2005

EP Publication Date:

31/08/2005

PCT Publication Date:

08/09/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/11/2001

EP B1 Publication Date:

31/08/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/02/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/02/2000

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:

SCHMUTZ Markus

Address:

Switzerland (CH)

Priority

1

Priority Number:

259910

Priority Date:

01/03/1999

Priority Country:

United States (US)

2

Priority Number:

259911

Priority Date:

01/03/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 25/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/02/2019

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages